PADI4 and rheumatoid arthritis: Supported by the proven expression of PAD2 and PAD4 in RA synovia [119], these findings suggest that in arthritic joints, citrullinated COL2 could inhibit the LAIR-1-mediated downregulation of autoimmune responses, and thus, perpetuate the disease.